Contact Us

Boston Scientific Enteryx Device
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

What medical condition prompted the use of the device?

Please describe any problems or injuries caused by the product:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


FDA Reviews Boston Scientific Acid Reflux Device After Death

Aug 15, 2004 | AP

The Food and Drug Administration is reviewing the death last month of an elderly woman after she was treated with a Boston Scientific Corp. device for acid reflux disease.

The FDA is also looking at injuries in six other patients treated with the Enteryx device.

The review comes as Boston Scientific grapples with a month-old recall of its lucrative drug-coated heart stent.

Nearly 100,000 Taxus and Express 2 model stents have been recalled since July 2 because of a manufacturing defect.

In the Enteryx review, the FDA is looking into whether physician technique or the device itself triggered the woman's death, which occurred when her aorta ruptured. The Enteryx device is used to inject a plastic substance into the esophagus. The substance is designed to reduce the symptoms of acid reflux disease.

"At this time there doesn't appear to be a problem with the device," FDA spokeswoman Kathleen Quinn said.

Paul Donovan, a spokesman for Boston Scientific, said the company is recommending that the product's label be changed to stress the importance of closely following directions for use.

"We are going to work closely with the FDA," Donovan said.

Boston Scientific's stock has fallen nearly 25 percent since just before the beginning of July, when the stent recalls began.

Enteryx, which costs about $1,700, has been used in about 2,000 procedures since it was introduced in April 2003.

In acid reflux disease, the contents of the stomach back up into the esophagus. Enteryx is one of a handful of minimally invasive treatments designed to offer relief without daily medication.


Related articles Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo